Skip Nav Destination
Article navigation
Correspondence|
August 1994
Is Aprotinin Worth the Risk in Total Hip Replacement?
Department of Anesthesiology Head of Autologous Blood Service; Department of Orthopedics; Associate Professor, Department of Orthopedics; Klinik für Anaesthesiologic und Operative Intensivmedizin der Universitat zu Köln Joseph-Stelzmann-Strase 9 D-50924 Koln, Germany
Anesthesiology August 1994, Vol. 81, 517.
Citation
Stefan-Mario Kasper, Joachim Schmidt, Jürgen Rütt; Is Aprotinin Worth the Risk in Total Hip Replacement?. Anesthesiology 1994; 81:517 doi: https://doi.org/10.1097/00000542-199408000-00038
Download citation file:
Citing articles via
Most Viewed
Related Articles
Aprotinin Decreases Blood Loss and Homologous Transfusions in Patients Undergoing Major Orthopedic Surgery
Anesthesiology (January 1998)
Do Antifibrinolytics Reduce Allogeneic Blood Transfusion in Orthopedic Surgery?
Anesthesiology (November 2006)
Do Hospitals Performing Frequent Neuraxial Anesthesia for Hip and Knee Replacements Have Better Outcomes?
Anesthesiology (September 2018)
Effects of Aprotinin Dosage on Renal Function: An Analysis of 8,548 Cardiac Surgical Patients Treated with Different Dosages of Aprotinin
Anesthesiology (February 2008)
Anesthetic Management and Surgical Site Infections in Total Hip or Knee Replacement: A Population-based Study
Anesthesiology (August 2010)
